You are here

Article Text

Article menu
Download PDFPDF
Treatment
Review: aspirin was effective for primary prevention of stroke in women and MI in men but increased major bleeding

https://doi.org/10.1136/ebn.9.3.76

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Berger JS, Roncaglioni MC, Avanzini F, et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295:306–13.OpenUrlCrossRefPubMedWeb of Science

    Q What are the benefits and risks of aspirin for primary prevention of cardiovascular (CV) disease in women and men?

    METHODS

    Embedded ImageData sources:

    Medline (1966 to March 2005), bibliographies of retrieved articles, and monitoring of major scientific meetings.

    Embedded ImageStudy selection and assessment:

    randomised controlled trials (RCTs) that allocated participants to aspirin or a control group for primary prevention of CV disease and outcomes included CV mortality, myocardial infarction (MI), and stroke. Quality of individual studies was assessed based on allocation concealment, follow up, and objectivity of outcome assessments. 6 RCTs (51 342 women and 44 114 men, mean age 55–65 y) met the …

    View Full Text

    Footnotes

    • For correspondence: Dr D L Brown, SUNY-Stony Brook Health Sciences Center, Stony Brook, NY, USA. david.brown{at}stonybrook.edu

    • Source of funding: not stated.